Literature DB >> 3974969

Noncontraceptive estrogens and progestins: use patterns over time.

D L Kennedy, C Baum, M B Forbes.   

Abstract

The use of noncontraceptive estrogens and progestins, particularly in menopausal women, has been a subject of considerable controversy during the past decade. Reported is a review of overall trends in the use of these drugs from 1966 to 1983 and a more indepth qualitative and quantitative description of their use during 1983. The use of these estrogens and progestins appears to be increasing again. The estrogens are apparently being used at lower doses than in the past, and there is a trend toward using estrogens and progestins concomitantly. Exclusive of oral contraceptives, enough oral estrogen was purchased during 1983 to treat an average of 2.3 million people each day, while oral progestin purchases could have supplied 129,000 people daily.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3974969

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

Review 1.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

Review 2.  Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and hormone replacement therapy.

Authors:  Jayne C Lucke; Phillippa C Diedrichs; Bradley Partridge; Wayne D Hall
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

3.  The associations of hormone replacement therapy and preventive practices in minority women.

Authors:  Kalpana Ganesan; Senait Teklehaimanot; Merlyn Asuncion
Journal:  J Natl Med Assoc       Date:  2005-01       Impact factor: 1.798

4.  Hormone replacement therapy: assessment of present use, costs, and trends.

Authors:  J Townsend
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

5.  The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.

Authors:  Ronald E Gangnon; Brian L Sprague; Natasha K Stout; Oguz Alagoz; Harald Weedon-Fekjær; Theodore R Holford; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-18       Impact factor: 4.254

6.  Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.

Authors:  E Hemminki; D L Kennedy; C Baum; S M McKinlay
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

7.  Are women using postmenopausal estrogens? A community survey.

Authors:  R B Harris; A Laws; V M Reddy; A King; W L Haskell
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

Review 8.  Population-based trends in lung cancer incidence in women.

Authors:  Brian L Egleston; Sibele I Meireles; Douglas B Flieder; Margie L Clapper
Journal:  Semin Oncol       Date:  2009-12       Impact factor: 4.929

9.  Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women.

Authors:  P Topo; T Klaukka; E Hemminki; A Uutela
Journal:  J Epidemiol Community Health       Date:  1991-12       Impact factor: 3.710

10.  A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Kathleen A Cronin
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.